Alyeska Investment Group
SCPH

Alyeska Investment Group’s scPharmaceuticals SCPH Stock Holding History

Alyeska Investment Group’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-355,690
Closed -$2.37M – 822
2021
Q1 		$2.37M Hold
355,690
– – 0.03% 444
2020
Q4 		$1.88M Sell
355,690
-2,845
-0.8% -$22.3K 0.03% 377
2020
Q3 		$2.67M Sell
358,535
-30,068
-8% -$235K 0.04% 319
2020
Q2 		$2.86M Buy
+388,603
New +$3.41M 0.04% 327
2019
Q1 		– Sell
-177,135
Closed -$666K – 453
2018
Q4 		$666K Sell
177,135
-53,684
-23% -$252K 0.01% 323
2018
Q3 		$1.35M Hold
230,819
– – 0.02% 329
2018
Q2 		$1.31M Buy
230,819
+7,381
+3% +$75.8K 0.01% 378
2018
Q1 		$2.77M Buy
223,438
+48,438
+28% +$651K 0.02% 328
2017
Q4 		$2.12M Buy
+175,000
New +$2.47M 0.02% 335

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return